tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogomaz, SA; Gross, GJ; Krylatov, AV; Lishmanov, AIu; Loktiushina, BA; Maslov, LN; Naryzhaia, NV; Solenkova, NV; Stefano, JB | 1 |
| Bogomaz, SA; Lishmanov, IuB; Maslov, LN; Naumova, AV | 1 |
2 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Interactions of peripheral mu-opioid receptors and K(ATP)-channels in regulation of cardiac electrical stability in ischemia, reperfusion, and postinfarction cardiosclerosis].
Topics: Animals; Electrocardiography; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Naloxone; Oligopeptides; Peptide Fragments; Peptides; Potassium Channels; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Opioid, mu; Sclerosis; Somatostatin | 2002 |
[mu-Opiate receptor activation and increase in heart resistance to ischemic and reperfusion injury].
Topics: Animals; Blood Pressure; Electrocardiography; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; In Vitro Techniques; Ligands; Myocardial Ischemia; Myocardial Reperfusion Injury; Narcotic Antagonists; Oligopeptides; Peptides; Rats; Rats, Wistar; Receptors, Opioid, mu | 1998 |